AIM Vaccine Co. Ltd.

10/30/2024 | Press release | Distributed by Public on 10/29/2024 16:10

VOLUNTARY ANNOUNCEMENT - MRNA RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE OBTAINED THE CLINICAL TRIAL APPROVAL